相关实验视频

Updated: Jul 29, 2025

Intravitreal Injections in the Ovine Eye

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

扩大VEGF抑制的药理动力学和药理动力学理由增加静脉内阿弗利伯塞普特剂量

Daniele Veritti¹, Valentina Sarao^1,2, Francesco Di Bin¹

¹Department of Medicine-Ophthalmology, University of Udine, 33100 Udine, Italy.

|May 27, 2023

概括

新的建模表明,每12-15周服用8毫克的阿弗利塞普特可以有效地抑制血管内皮生长因子 (VEGF),通过保持自由VEGF水平低于0.001%,有效地抑制血管内皮生长因子 (VEGF). 这样可以优化对内疾病的治疗.

科学领域:

眼科医生眼科眼科
药理动力学药理动力学
数学建模的数学建模

背景情况:

静脉内膜阿弗利塞普特用于治疗各种眼睛疾病.
了解最佳剂量及其对自由血管内皮生长因子 (VEGF) 的影响至关重要.
特别研究了8mg的剂量.

研究的目的:

评估不同阿弗利塞普特剂量和治疗计划对药物静脉度的影响.
在各种处理方案下,模拟自由VEGF与总VEGF的比例.
确定有效的治疗方案来抑制VEGF.

主要方法:

使用Wolfram Mathematica开发了一个时间依赖的数学模型.
该模型模拟了0.5毫克,2毫克和8毫克剂量的静脉内阿弗利塞普特度.
随着时间的推移,对不同剂量间隔的自由VEGF百分比水平进行了估计.

主要成果:

模拟表明,每12-15周服用8毫克aflibercept可以保持VEGF在值以下的水平.
这些治疗间隔使自由VEGF比率保持在0.001%以下.
该模型确定了固定治疗方案的潜在临床应用.

结论:

每12-15周 (q12-q15) 服用固定8毫克阿弗利伯塞普的疗程,可提供足够的静脉内VEGF抑制.
这种剂量策略是有效的管理由VEGF驱动的条件.
这些发现支持aflibercept治疗的优化治疗方案.

关键词:

一个自由的接受.与年龄相关的黄斑变性.这是一个沉重的负担.静脉内注射静脉内注射静脉内注射静脉内注射数学模型是一个数学模型.新血管新血管疾病

更多相关视频

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Published on: August 11, 2023

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...